跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 47,472 条关于
“YA II PN, LTD”
全部
47,472
临床试验
35,666
药物
1,837
机构
4,113
资讯
5,856
去年
FibroBiologics Secures $25M Equity Purchase Agreement to Advance Clinical Programs in Multiple Diseases
去年
Kiromic BioPharma's Deltacel-01 Shows Promise in Solid Tumors, Faces Financial Hurdles
去年
Predictive Oncology Secures $10M Equity Agreement to Advance AI-Driven Cancer Drug Discovery
去年
FibroBiologics Partners with Charles River to Advance Fibroblast-Based Therapy for Diabetic Foot Ulcers
去年
Lumosa Therapeutics' LT3001 Shows Promise in Phase II Acute Ischemic Stroke Trial
去年
Yoda Therapeutics Initiates Phase 2 Trial of YA-101 for Multiple System Atrophy
上个月
Dasher Neuroscience Completes Patient Enrollment in Phase 2 Trial of YA-101 for Multiple System Atrophy
去年
Mirdametinib Demonstrates Significant Tumor Reduction and Improved Quality of Life in NF1-Associated Plexiform Neurofibroma
去年
Mirdametinib Shows Deep Responses in NF1-Associated Plexiform Neurofibromas
去年
EU Committee Recommends AstraZeneca and Ionis' Wainzua for ATTRv-PN
第 1 页,共 586 页
上一页
下一页